Introduction
Infection with the human polyomavirus JC virus (JCV) is usually acquired in the first decade of life with seroconversion rates of more than 90 % in the adult (Arthur & Shah, 1989 ; Kitamura et al., 1990 ; Major et al., 1992) . Primary contact leads to lifelong asymptomatic persistence in the kidney (Chesters et al., 1983 ; Do$ rries & Elsner, 1991 ; Flaegstad et al., 1991) and the CNS (Chesters et al., 1983 ; Elsner & Do$ rries, 1992) . Additionally, JCV DNA is found in tonsillar cells, leukocytes and the bone marrow (Do$ rries et al., 1994 ; Monaco et al., 1996 ; Myers et al., 1989) . Activation of persistent virus infection occurs frequently without causing disease (Coleman et al., 1980) . Only in cases of severe impairment of immunocompetence (Schmidbauer et al., 1990 ; Walker & Padgett, 1983) may cytolytic JCV infection of oligodendrocytes cause the fatal CNS disease progressive multifocal leukoencephalopathy (PML). Although the number of cases is steadily increasing due to the AIDS epidemic, the pathomechanisms leading to PML are not yet understood. As well as the role of Author for correspondence : Kristina Do$ rries.
Fax j49 931 201 3934. e-mail Doerries!mail.uni-wuerzburg.de and in four kidney specimens with two TCR subtypes. Altogether, seven TCR subtypes were identified. One in each group represented single promoter element TCRs without duplication of sequences. The TCR of the major variant JCV-W1 was comparable in sequence and structure to that of the PML prototype JCV Mad-1 DNA. The identification of dominant PML-derived JCV TCR subtypes in most persistently infected individuals suggests that rearrangements of the JCV TCR can be associated with the persistent state of infection. However, it appears unlikely that PML-associated JCV subtypes are generated anew in each individual host in the course of persistence. The findings rather suggest that a limited number of stable JCV subtypes circulate in different geographical regions of the world.
severe impairment of immunological surveillance, genomic heterogeneity of JCV DNA was assumed to be associated with development of the disease.
Characterization of JCV genomes in PML tissue revealed that coding DNA segments are conserved with changes at the nucleotide level not necessarily leading to changes in the amino acid composition of proteins. Some of the changes in the carboxy-terminal segments of VP1, T antigen and the intergenic region are conserved in clustered geographical groups. Therefore, they are used as a basis for the so-called V-T genotyping scheme (Agostini et al., 1997 ; Ault & Stoner, 1992 ; Frisque et al., 1984 ; Loeber & Do$ rries, 1988) . The noncoding DNA segment containing the origin of DNA replication and the transcriptional control region (TCR) is conserved with respect to the nucleotide sequence, but heterogeneous in its structure (Agostini et al., 1997 ; Grinnell et al., 1983 ; Martin et al., 1985 ; Matsuda et al., 1987) . Promoter elements in PML are classified into TCR type I and TCR type II DNA. A prerequisite for TCR type I JCV genomes is the fusion of the TATA box and following sequences leading to repetition of elements that include the TATA box. TCR type II JCV DNA has one TATA box proximal to the early mRNA initiation site that is not included in the repeated elements. Both subtypes have conserved factor binding sites in common that are framed by highly variable sequences preferentially used as sites of recombination (Agostini et al., 1997 ; Ault & Stoner, 1993 ; Loeber & Do$ rries, 1988) . TCRs with unique DNA sequences of single promoter elements were detected in kidney and urine (Flaegstad et al., 1991 ; Loeber & Do$ rries, 1988 ; Tominaga et al., 1992 ; Yogo et al., 1990 Yogo et al., , 1991 . In addition to genotype and TCR variants, defective polyomavirus genomes were observed in semipermissive cell cultures and tissue. Assuming that such molecules might be generated in the course of persistent JCV infection, a possible role of a defective DNA population with extensive deletions or substitutions within coding sequences has been repeatedly discussed (Grinnell et al., 1982 ; McCance, 1983 ; Yoshiike et al., 1982) .
Comparison of JCV DNA populations with a high rate of virus replication in PML brain, and those exhibiting low rates in persistently infected kidney tissue demonstrated JCV DNA molecules of different TCR types but with highly related coding sequences in the respective tissue of one patient (Ault & Stoner, 1994 ; Do$ rries, 1984 ; Loeber & Do$ rries, 1988) . Promoter elements of TCR types from cytolytically infected brain tissue included complex rearrangements. In contrast, virus from histopathologically healthy kidney tissue exhibited control regions without extensive sequence duplications. From these findings, the assumption was drawn that the parental rather attenuated JCV archetype may circulate in the human population, invading the CNS during persistence. It appeared to be likely that the PML-type of JCV variants might subsequently be generated anew in each host from the archetype TCR during asymptomatic activation processes (Iida et al., 1993 ; Kato et al., 1994 ; Yogo et al., 1990) . The detection of minor heterogeneity in JCV populations from PML brain supported this hypothesis. However, the time-scale of rearrangements in the course of infection and the extent of genomic changes in the CNS prior to disease remained uncertain.
In an attempt to elucidate the extent of the genetic heterogeneity in persistently infected organs, we determined the genomic complexity of JCV genomes in CNS and kidney tissue without histopathological changes typical for polyomavirus-induced disease. Analysis of JCV rearrangements in the TCR revealed the presence of one dominant JCV TCR subtype among minor TCR variants in both organs. The TCR was found to be identical in sequence to that of PML-derived JCV TCR types, thus demonstrating that PML-type viruses can similarly invade the CNS and the kidney prior to disease. The characterization of a PML-type TCR as the dominant virus type in peripheral tissue of immunocompetent individuals suggests that rearranged TCR types are circulating in the human population and are not necessarily generated in each host.
Methods
Patient material. Autopsy material was analysed from CNS and kidney of 13 patients from Western Europe. Brain samples were examined HJA from patients with multiple sclerosis, heart failure and carcinomas of the rectum and liver. Kidney material was from eight patients with herpes simplex virus (HSV) encephalitis, Creutzfeldt-Jacob disease, liver cirrhosis, leukaemia, aneurysm and cardio-pulmonal failure. Cellular DNA was prepared by standard procedures (Do$ rries et al., 1994 ; Elsner & Do$ rries, 1992) .
Cellular gene libraries from human brain and kidney tissue. JCV genomes were cloned from tissue with the restriction enzyme BamHI in the phage lambda replacement vector NM1151 (Elsner & Do$ rries, 1992) . Cellular DNA was cleaved to completion and cloning was performed essentially as described by Sambrook et al. (1989) . Between 1i10& and 6i10& clones\µg cellular DNA were achieved by in vitro packaging ; 1-3i10' clones per specimen were analysed by plaque hybridization with radioactive genomic JCV DNA probes (Elsner & Do$ rries, 1992) . Characterization of cloned JCV genomes was performed by restriction endonuclease cleavage and followed by Southern blot analysis.
Amplification of JCV-specific DNA by PCR. PCR was performed with primer pairs either covering a DNA fragment of the early coding region (TEP1\PEP2) or the non-coding region flanked by conserved coding sequences (JCV71\72). Cellular DNA (1 µg) was amplified in 2n5 mM MgCl # in a reaction volume of 50 µl with 1 U of Taq polymerase. Cycling was as described previously (Do$ rries et al., 1994 ; Elsner & Do$ rries, 1992) . As a precaution against PCR contamination, all reactions were performed in parallel with a complete set of controls. Negative controls included testing of the buffer components in duplicate prior to and after preparation of experimental reactions in laboratories used exclusively for PCR. Characterization of amplification products was performed in another laboratory by electrophoresis and radioactive hybridization of Southern blots with a JCV-specific internal oligonucleotide or a specific ssRNA probe (Do$ rries et al., 1994 ; Elsner & Do$ rries, 1992) .
Cloning and typing of JCV control region elements. For cloning, JCV-specific products were amplified by PCR with the primer pair JCV71\72 containing an artificial BamHI and EcoRI restriction site, respectively (Elsner & Do$ rries, 1992) , and inserted into the bacterial vector pBluescript SK(j). Recombinants were selected by colony hybridization with a radioactive ssRNA probe (Elsner & Do$ rries, 1992) . JCV prototypes were cloned by the same strategy (Frisque et al., 1984 ; Loeber & Do$ rries, 1988) . The characterization of JCV inserts was performed with the restriction enzymes BamHI\EcoRI and StyI followed by electrophoresis on agarose gels.
Analysis of cloned JCV DNA segments by nucleotide sequencing. DNA sequencing of the complete JCV control region between the start codon of the putative agnogene and that of the T antigen gene was performed from one-tube plasmid mini-preparations (DelSal et al., 1988) . Isolated DNA was denatured with 0n2 M NaOH (10 min, 65 mC), neutralized by 0n4 vol. 5 M ammonium acetate (pH 5n5) and ethanol-precipitated. For sequencing virus-specific internal oligonucleotides JCV 69, 87, 60, 53 and pBluescript primers 16 and 31 were used (Do$ rries et al., 1994) . Sequencing was performed with the enzyme Sequenase and $&S-dATP (USB, Amersham) essentially as recommended by the supplier.
Results

Complexity of JCV DNA in persistently infected brain and kidney tissue
For characterization of the JCV DNA population in persistently infected tissue, autopsy specimens were selected from brain parenchyma and from the renal medulla of patients with CNS diseases other than PML or with systemic disorders (Table 1 ). In none of the cases, neurological symptoms or histopathological patterns indicative of PML were observed. Cellular DNA was subjected to amplification of JCV DNA. One primer pair was specific for the T antigen coding region and resulted in a fragment of 199 bp in length. A second primer pair spanning the control region amplified a fragment of about 600 bp in length (Elsner & Do$ rries, 1992) . The specificity of electrophoretically separated products was confirmed by Southern blotting and JCV-specific radioactive hybridization. PCR analysis revealed the presence of JCV-specific DNA sequences in at least one of five brain specimens and one of four kidney specimens from each case ( Table 1) .
In order to analyse the complexity of JCV DNA molecules in persistently infected organs, the complete genome was examined by cloning of JCV genomes from CNS tissue in two cases (B20, B23) and from kidney tissue in three cases (K1, K3, K4). The single BamHI restriction site in the early coding region of the JCV genome was used for insertion in phage lambda NM1151. Characterization of cloned JCV molecules was performed by restriction cleavage with the enzyme BamHI and combinations of BamHI with EcoRI, PstI, BglII, XbaI, NsiI, HpaII, HincII or HindIII followed by Southern blot analysis. The analyses revealed a JCV insert of 5 kb in length in all clones from the brain and kidney. Comparison of the DNA fragment pattern with that of the JCV prototypes showed the characteristic JCV pattern with all enzymes used (data not shown). This finding demonstrated that cloned viral DNA molecules in persistently infected tissue were intact without major rearrangements of coding sequences.
Comparison of JCV TCR subtype populations in brain and kidney tissue by restriction mapping
Analysis of full-length JCV DNA with the enzyme combination BamHI\PvuII focussed on the TCR. Palindromes of the restriction enzyme PvuII are located close to and within the non-coding region of the JCV genome resulting mainly in three DNA fragments spanning conserved coding DNA segments and a variable fragment C including the viral control region. In one case, two out of 16 brain-derived clones exhibited heterogeneous mobility of fragment C. One was not related to the prototype segment C, whereas the second was comparable in length to that of JCV GS\B (991 bp) (Fig. 1 a,  lanes 4 and 10) . In the remaining clones, fragment C was comparable to that of JCV Mad-1 (1093 bp). In contrast, clones from the second brain specimen and all kidney-derived clones from three cases had an identical fragment pattern comparable in length to that of JCV Mad-1 (Fig. 1 b) .
To determine the TCR heterogeneity further, JCV DNA was amplified by PCR on brain tissue from three and on kidney tissue from five additional cases (Table 2) . Products were directly cloned to avoid loss of less common JCV subtypes involved. Twenty to 40 JCV-specific clones per case were isolated, thus giving a representative view on the JCV population present. A total of 91 clones was established from CNS tissue, and 227 clones were achieved from kidney tissue. Restriction cleavage of virus-specific inserts with the cloning enzymes BamHI\EcoRI revealed the presence of heterogeneous JCV TCR fragments in 67 % of the CNS samples and in 80 % of the kidney samples.
A detailed analysis of the JCV control region was performed with the restriction enzyme StyI. The enzyme cleaved the insert into 5-6 fragments ( Fig. 2 a, b) . The fragments A and B spanned sequences upstream of the origin of DNA replication and downstream of late coding sequences. Promoter elements were divided into 2-4 fragments as demonstrated by comparison with those of prototype TCR type I (JCV Mad-1), type II (JCV GS\B) and archetype DNA (JCV GS\K). In CNS and kidney tissue, seven and two different TCR StyI patterns were identified, respectively (Figs 2 and 3 a, b, Table 2 ). Pattern JCV-W1 was comparable to that of prototype JCV Mad-1. JCV-W6 was similar to that of prototype JCV GS\B, and JCV-W7 was comparable to that of archetype JCV GS\K. Four additional patterns, JCV-W2 to JCV-W5, were detected. The JCV-W2 type exhibited DNA fragments related to those of JCV Mad-1, although the entire insert length was about 100 bp longer ; this was due to a duplicated band. Fragment pattern JCV-W4 was also related to the Mad-1 subtype. The missing 100 bp band was reflected in the reduced length of the entire insert. JCV-W5 had a pattern with a smaller fragment C that showed similarities to that of the archetype DNA. JCV-W3 clones exhibited a pattern that was not comparable to any of the other JCV TCR types. Thus, in addition to a new as yet unknown TCR pattern, control regions similar to those of PML-derived JCV genomes at both sites of infection were found.
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Nucleotide sequence of variant control regions from persistently infected tissue
The detection of JCV TCR segments of the PML-type in persistently infected tissue was rather unexpected. Therefore, the JCV control region elements were further characterized by DNA sequencing (Fig. 4) . To improve the comparison of divergent DNA sequences, the JCV control region was divided into the origin of DNA replication (ori) and seven DNA segments (A-E, F1, F2) with reference to Ault & Stoner (1993) . On the early side of all TCR types, ori sequences were highly conserved. The length of TCR type I control regions varied between 726 and 522 bp (Fig. 2) . The DNA segment A, a TATA box element, was fused to nucleotides of segment C and segment E. In TCR type II DNA, the control region varied in length between 581 and 662 bp. Segment A was fused to segment B and the following segment C. In TCR type I, segment C was conserved, whereas segment C of TCR type II was variable in length with deletions of 8-21 bp at the 5h end. Segment B separated segments A and C leading to repeated elements without TATA box sequences. These conserved sequence elements were framed by variable sequences leading to differentially constructed repeated elements. Downstream sequences included a 16-18 bp segment E in both TCR types. In TCR type II, these were followed by the 3h-truncated forms of the 66 bp archetype segment D. The sequence of segments F1, F2 and Agno downstream of the initiation codon of the putative agnogene was conserved in six out of seven subtypes identified. Rearranged segments E through to Agno were identified only once (Fig. 5, W6 ). This TCR subtype was previously observed in PML tissue (Loeber & Do$ rries, 1988) .
Single point mutations were repeatedly detected. However, comparison of different clones of the same subtype revealed random distribution of the changes. This suggested that single point mutations were probably introduced at least in part by the PCR amplification step. The genotype defining single base change on the late side of ori at the archetype TCR position 133 was represented by the nucleotide adenosine in all cases. This is a common finding in American and European isolates (Yogo et al., 1990) .
JCV TCR subtype lineages in persistently infected individuals
The JCV control regions identified so far were divided into three types. Type I and type II both contain repeated conserved elements that might even include the TATA box or extend to late coding sequences. In contrast, the so-called archetype TCR is formed by unique sequences and a complete segment D that is located downstream of the conserved region C. As shown in Fig. 5 , the major JCV subtype W1 carried a type I TCR. The DNA nucleotide sequence was almost identical to that of the JCV prototype Mad-1. Additionally, two rearranged TCR type I regions were identified differing only in the number of the first conserved element. In JCV-W2, this element was present in triplicate. JCV-W4 represented a single TCR element identical in sequence to that of the first conserved type I element. The downstream segments E, F1 and F2 were all similarly arranged. Four TCR type II variants were identified by the presence of segment B following the TATA box. JCV-W6 was identical in sequence and structure to that of JCV GS\B (Loeber & Do$ rries, 1988) . In the early segment, JCV-W5 was highly related to JCV-W6, whereas the late part, including the segments F1 through to Agno, was comparable to that of the archetype. JCV-W5 and JCV-W6 both carried truncated forms of the archetype related segment D suggesting a close HJE Fig. 4 . Alignment of the nucleotide sequence of JCV subtypes isolated from persistently infected individuals. The nucleotide sequences of JCV TCR subtypes W1, W2, W4, W3, W5, W7 from German individuals are aligned from the core origin of DNA replication to the start codon of the agnogene. Nucleotide numbering is according to Loeber & Do$ rries (1988) . The DNA strand has the polarity of the late mRNA. The start codon for the agnogene is indicated by an arrow. The sequence is divided in seven boxed segments (A, B, C, D, E, F1, F2) ; shading is identical to that in Fig. 5 . ' A ' represents the TATA box and T antigen binding sites are indicated. Deletions are marked by a dash. Fig. 5 . Structure of the promoter elements of JCV TCR type I (JCV W1, W2, W4) and type II (JCV W6, W5, W3, W7) isolated from persistently infected individuals. The DNA sequence of the A-F2 segments is identical to that in Fig.  4 . The initiation codon for the putative agnogene is indicated by an arrow. Agno represents the putative agnogene coding DNA segment repeated in the JCV-W6 and the GS/B prototype TCR. Segment length is given in bp ; AT represents the TATA box ; ori, origin of DNA replication. *, Nucleotides are numbered according to Loeber & Do$ rries (1988) . v, Deletion of 23 bp ; -, conserved sequences.
C. Elsner and K. Do$ rries C. Elsner and K. Do$ rries relationship between these TCR variants. In JCV-W3, segment D is eliminated and a deletion at the 3h-end of segment C and at the 5h-end of the second B element could be observed. JCV-W7 represented the archetype, which is thought to be the ancestral type of all differentially arranged TCRs. The TCR classification demonstrates that both lineages of rearranged TCR types and the archetype TCR were present in persistently infected individuals in Western Europe.
Distribution of JCV TCR subtypes in infected organs
Comparison of the TCR types in brain tissue revealed the presence of major and minor subtypes ( Table 2 ). The rate of minor JCV types varied between 2n6 and 30n8 %. Major types were found at a rate between 53 and 100 %. The PMLassociated subtypes JCV-W1 and JCV-W6 were the dominant types in brain tissue with rates between 87n5 and 100 %. Interestingly, the archetype JCV-W7 was present at a rate of 53 % in one brain specimen. This was higher than the closely related duplicated TCR JCV-W6 (30n8 %) in the same specimen. Although this finding suggested extensive rearrangements in this patient, variant molecules were observed only in two out of five cases. Thus, rearranged JCV TCRs are probably not regularly present in persistently infected brain tissue. In the kidney, JCV TCR populations were similarly homogeneous in about 50 % of all cases (seven out of 13 cases). The dominant TCR was the PML-derived prototype Mad-1. Only one minor variant was detected at rates between 2n4 and 25 % in the four heterogeneous DNA populations. This subtype contained a single element TCR closely related to the Mad-1 subtype. The same subtype was additionally detected in brain tissue ; therefore the TCR type is not tissue-specific.
TCR JCV-W1 was the major type identified in 12 of the 13 patients irrespective of the tissue analysed. This revealed that PML-type variants persisted in the CNS and the kidney of individuals without JCV-associated disease. From the distribution of TCR subtypes in kidney and brain tissue, rearrangements in the CNS of individual patients cannot be excluded. However, it appears to be unlikely that changes in the TCR are restricted to the CNS. The identification of the JCV Mad-1 (JCV-W1) prototype as the only variant in the majority of cases rather suggested the presence of conserved stable JCV TCR subtypes circulating in the human population.
Discussion
The extensive divergence of the JCV control region in PML patients gave rise to the hypothesis that the generation of heterogeneous TCRs might be involved in virulence during the pathogenic process. It was believed that JCV genomes may change from an attenuated persisting subtype with single promoter elements to a virulent virus type with rearranged duplicated promoter elements growing efficiently in the CNS. This hypothesis implicated that the state of disease is preceded by progressive selection of JCV subtypes leading to a heterogeneous JCV population in persistently infected CNS tissue. Besides a hypervariability of the JCV TCR in the noncoding region of the genome, DNA rearrangements of coding sequences were described in brain tissue of a PML patient and as a result of JCV growth in tissue culture (Elsner & Do$ rries, 1992 ; Martin et al., 1982 ; Matsuda et al., 1987 ; Rentier Delrue et al., 1981) . Although detected in vivo only in rare cases and in the late stages of disease, it was conceivable that JCV genomes with major changes in the coding region of the genome might become prevalent in the attenuated persistent state of infection. To further evaluate the role of JCV variants in the pathogenesis of PML, we examined the genomic structure of JCV DNA in tissue of patients without histopathological changes indicative for JCV-associated disease.
Persistent infection was confirmed by PCR amplification of JCV DNA. However, amplification of JCV DNA fragments alone does not give evidence of the complexity of viral genomes, and full-length genomic JCV PCR is not sensitive enough for JCV detection in persistence (own observations). Therefore, JCV DNA from tissue was cloned in a phage lambda gene library and then analysed. Characterization of JCVspecific inserts revealed exclusively the presence of full-length JCV genomes. Extensive restriction enzyme mapping gave no indication of major changes within coding DNA segments. This confirmed the high conservation rate of the genomic structure (Grinnell et al., 1982 ; Martin et al., 1982 ; Rentier Delrue et al., 1981) and suggested that rearranged coding DNA segments are not regularly generated in the persistent state of infection. Therefore, it appears rather unlikely that defective JCV genomes play a major role in polyomavirus persistence.
In contrast to the conserved coding region, restriction analysis of the non-coding region revealed heterogeneity of DNA segments carrying the TCR. Most of the genomes revealed fragment lengths similar to that of the rearranged PML prototype Mad-1 DNA. In view of reports on JCV archetype TCRs with single elements in healthy individuals (Markowitz et al., 1991 ; Yogo et al., 1990 Yogo et al., , 1991 , this finding suggested a more extensive involvement of PML-associated promoter elements in persistent infection than thus far assumed (Sundsfjord et al., 1994) . To evaluate this finding further, the TCR populations were analysed by PCR of the non-coding region and following molecular characterization. Loss of minor JCV variants was avoided by cloning of the products prior to further analyses. Using this strategy, the clone number per individual sample probably reflected the concentration of JCV DNA, which appeared to be higher in the renal medulla than in the CNS Stoner et al., 1996 ; Tominaga et al., 1992) .
Detailed sequence analysis of the JCV control region revealed the presence of seven different TCRs in persistently infected tissue samples from 13 patients. The most prominent types at both sites of infection were identical to those of the prototypes JCV Mad-1 and GS\B isolated from an American and a German PML brain. The archetype structure described HJG earlier as the dominant TCR type in renal infection was detected as a minor population in brain tissue. This confirmed the results from the cloning experiments above, but is in contrast with the assumed predominance of JCV archetype TCRs in persistently infected individuals (Markowitz et al., 1991 ; Sundsfjord et al., 1994 ; Yogo et al., 1991 Yogo et al., b, 1990 .
In the attempt to find an explanation for this discrepancy, the possible generation of artificial amplification products by PCR-dependent recombination was taken into consideration. Although recombination rates of almost 5 % were suggested, depending on the PCR target DNA used (Meyerhans et al., 1990) , in our experiments the major TCR subtypes were not only detected by PCR amplification but also in the cloned fulllength genomes. Therefore, PCR recombination and PCR contamination appeared to be rather unlikely. Besides the extensive control of the PCR experiments, the strongest argument against contamination is the detection of the same rate of JCV Mad-1-like TCRs in the classical cloning approach. Additionally, analysis of the V-T intergenic genotype linked to the described TCRs has been performed. In contrast to the Mad-1 genome isolated from a PML patient in the USA, the JCV-W1 genomes from persistently infected tissue are linked to coding regions of V-T genotype 2. This confirms that the JCV-W1 molecules are unique isolates. Interestingly, V-T genotype 1 sequences were described in urine of individuals from Northern Europe (Yogo et al., 1991 a) . In contrast, in the mixed American population almost all genotypes were found, with a predominance of genotypes 1 and 2 in white Caucasians (Agostini et al., 1997 ; Ault & Stoner, 1992) . Therefore, the detection of genotype 2 in our group might be representative of the geographical distribution of JCV genotypes in Western Europe.
The often propagated hypothesis that each individual carries a unique JCV TCR subtype generated from the circulating archetype (Yogo et al., 1990) is not only contradicted by the data presented here, but also by reports from the USA demonstrating a predominance of the Mad-1 type in persistently infected patients (Myers et al., 1989 ; White et al., 1992) . This points to a higher prevalence of the Mad-1 TCR in selected groups in the USA, whereas in others the archetype was found to be the dominant TCR. In Japan, almost exclusive archetype-related TCRs with minor changes were described in persistently infected tissue (Markowitz et al., 1991 ; Yogo et al., 1991 b) . These findings support the assumption that a limited number of TCR types dominate the virus population in different geographical regions of the world. The overgrowth of distinct TCRs might be explained by differential stability of TCR structures. Conserved stable TCR segments can be observed in type I and type II TCRs. In case of the Mad-1 isolate, even the complete control region exhibits high stability after a prolonged tissue culture history. This is demonstrated by conservation of the DNA sequence and structure of the direct JCV Mad-1 isolate (Br-1) and the cultured virus (Mad-1) from the same PML brain (Grinnell et al., 1983 ; Martin et al., 1982 ; Rentier Delrue et al., 1981) . In contrast to this stable organization, highly heterogeneous TCR populations and defective genomes were found after tissue culture passages of other TCRs (Howley et al., 1976 ; Martin et al., 1979 ; Osborn et al., 1974) . Therefore, it is conceivable that TCR structures may have evolved which are more or less susceptible to rearrangement events. Whether this is linked to the biological function of the respective promoter element is not yet determined.
Predominantly homogeneous TCRs or subtype populations with limited heterogeneity were detected at both sites of persistent infection. The major TCR subtype identified in healthy CNS was similar to that in lytically infected PML tissue. Therefore, a neurotropic selection of highly active JCV TCRs as a pathogenic event is rather unlikely. This does not exclude occasional rearrangements of TCRs in the course of persistence. The conditions leading to the development of variant TCR types are not yet known. In case of the archetype TCR, sequence rearrangements with only small variations from the archetype were observed in immunosuppressed renal transplant patients (Kitamura et al., 1994 b ; Yogo et al., 1990) . This suggested that immunosuppression may support TCR rearrangement. However, in the cases described here a correlation of immune impairment by malignancies and the presence of variant JCV DNA populations could not be found. In a search for other possible factors responsible for TCR rearrangements it became obvious that most studies concentrated on brain and kidney tissue, organs not exhibiting cellular replication activity. In this context, the characterization of lymphoid cells as a site of persistent JCV infection was noticeable (Do$ rries et al., 1994 ; Major et al., 1992) . This cell compartment includes actively dividing cell populations and it is conceivable that JCV TCR variants might be generated in the replicating cells.
The occurrence of a major PML-derived JCV TCR population in persistently infected tissue of individuals without PML suggests that highly active JCV TCRs circulate in Western Europe. They might already infect the individual host on primary contact and distribute to the target organs of infection. Therefore, it is not likely that active virus growth in the oligodendrocytes depends on the selection of glia cellspecific promoter elements. Activation of infection and induction of disease may rather be controlled by conditions closely related to the immunological competence of the viral host.
